These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27845212)

  • 1. Microbial biosensors to monitor the encapsulation effectiveness of Doxorubicin in chimeric advanced Drug Delivery Nano Systems: A calorimetric approach.
    Gardikis K; Signorelli M; Ferrario C; Schiraldi A; Fortina MG; Hatziantoniou S; Demetzos C; Fessas D
    Int J Pharm; 2017 Jan; 516(1-2):178-184. PubMed ID: 27845212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy.
    Gardikis K; Hatziantoniou S; Bucos M; Fessas D; Signorelli M; Felekis T; Zervou M; Screttas CG; Steele BR; Ionov M; Micha-Screttas M; Klajnert B; Bryszewska M; Demetzos C
    J Pharm Sci; 2010 Aug; 99(8):3561-71. PubMed ID: 20564386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Combined Effects of Ionizing Radiation and Dendritic Polymers Loaded with Doxorubicin on the MCF-7 Breast Cancer Cell Line].
    Zamulaeva IA; Pronyushkina KA; Matchuk ON; Yabbarov NG; Nikolskaya ED; Kondrasheva IG
    Radiats Biol Radioecol; 2015; 55(6):591-7. PubMed ID: 26964344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
    Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new chimeric drug delivery nano system (chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as doxorubicin's carrier. In vitro pharmacological studies.
    Gardikis K; Fessas D; Signorelli M; Dimas K; Tsimplouli C; Ionov M; Demetzos C
    J Nanosci Nanotechnol; 2011 May; 11(5):3764-72. PubMed ID: 21780367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine).
    Niidome T; Yamauchi H; Takahashi K; Naoyama K; Watanabe K; Mori T; Katayama Y
    J Biomater Sci Polym Ed; 2014; 25(13):1362-73. PubMed ID: 25040893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells.
    Morisco A; Accardo A; Tesauro D; Palumbo R; Benedetti E; Morelli G
    Biopolymers; 2011; 96(1):88-96. PubMed ID: 20560147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
    Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
    J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dendrimer surface functional groups on the release of doxorubicin from dendrimer carriers.
    Zhang M; Guo R; Kéri M; Bányai I; Zheng Y; Cao M; Cao X; Shi X
    J Phys Chem B; 2014 Feb; 118(6):1696-706. PubMed ID: 24467521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of doxorubicin: drug delivery system based on PAMAM dendrimers.
    Yabbarov NG; Posypanova GA; Vorontsov EA; Popova ON; Severin ES
    Biochemistry (Mosc); 2013 Aug; 78(8):884-94. PubMed ID: 24228876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.